{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:12:49Z","timestamp":1790968369496,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,5,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Chronic myelogenous leukemia (CML) is a malignant myeloproliferative disease arising from a hematopoietic stem cell expressing the BCR\/ABL fusion protein. Leukemic and dendritic cells (DCs) develop from the same transformed hematopoietic progenitors. How BCR\/ABL interferes with the immunoregulatory function of DCs in vivo is unknown. We analyzed the function of BCR\/ABL-expressing DCs in a retroviral-induced murine CML model using the glycoprotein of lymphocytic choriomeningitis virus as a model leukemia antigen. BCR\/ABL-expressing DCs were found in bone marrow, thymus, spleen, lymph nodes, and blood of CML mice. They were characterized by a low maturation status and induced only limited expansion of naive and memory cytotoxic T lymphocytes (CTLs). In addition, immunization with in vitro\u2013generated BCR\/ABL-expressing DCs induced lower frequencies of specific CTLs than immunization with control DCs. BCR\/ABL-expressing DCs preferentially homed to the thymus, whereas only few BCR\/ABL-expressing DCs reached the spleen. Our results indicate that BCR\/ABL-expressing DCs do not efficiently induce CML-specific T-cell responses resulting from low DC maturation and impaired homing to secondary lymphoid organs. In addition, BCR\/ABL-expressing DCs in the thymus may contribute to CML-specific tolerance induction of specific CTLs.<\/jats:p>","DOI":"10.1182\/blood-2008-05-156471","type":"journal-article","created":{"date-parts":[[2009,2,28]],"date-time":"2009-02-28T03:19:32Z","timestamp":1235791172000},"page":"4681-4689","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":27,"title":["Defective homing and impaired induction of cytotoxic T cells by BCR\/ABL-expressing dendritic cells"],"prefix":"10.1182","volume":"113","author":[{"given":"Sabine","family":"Mumprecht","sequence":"first","affiliation":[{"name":"Tumor Immunology, Department of Clinical Research, University of Berne, Berne; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Claus","sequence":"additional","affiliation":[{"name":"Tumor Immunology, Department of Clinical Research, University of Berne, Berne; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sch\u00fcrch","sequence":"additional","affiliation":[{"name":"Tumor Immunology, Department of Clinical Research, University of Berne, Berne; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Pavelic","sequence":"additional","affiliation":[{"name":"Tumor Immunology, Department of Clinical Research, University of Berne, Berne; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias S.","family":"Matter","sequence":"additional","affiliation":[{"name":"Tumor Immunology, Department of Clinical Research, University of Berne, Berne; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian F.","family":"Ochsenbein","sequence":"additional","affiliation":[{"name":"Tumor Immunology, Department of Clinical Research, University of Berne, Berne; and"},{"name":"Institute for Medical Oncology, Inselspital, Berne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111722345052500_B1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.","volume":"5","author":"Ren","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"2019111722345052500_B2","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","article-title":"The biology of CML blast crisis.","volume":"103","author":"Calabretta","year":"2004","journal-title":"Blood"},{"key":"2019111722345052500_B3","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI488","article-title":"Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia.","volume":"101","author":"Yotnda","year":"1998","journal-title":"J Clin Invest"},{"key":"2019111722345052500_B4","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1182\/blood.V87.9.3587.bloodjournal8793587","article-title":"Specific human cellular immunity to bcr-abl oncogene-derived peptides.","volume":"87","author":"Bocchia","year":"1996","journal-title":"Blood"},{"key":"2019111722345052500_B5","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1182\/blood-2003-01-0150","article-title":"Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.","volume":"102","author":"Rezvani","year":"2003","journal-title":"Blood"},{"key":"2019111722345052500_B6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells.","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"2019111722345052500_B7","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1182\/blood-2002-06-1841","article-title":"Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration.","volume":"101","author":"Dong","year":"2003","journal-title":"Blood"},{"key":"2019111722345052500_B8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.leukres.2005.11.028","article-title":"Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation.","volume":"30","author":"Orsini","year":"2006","journal-title":"Leuk Res"},{"key":"2019111722345052500_B9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2141.2002.03831.x","article-title":"Low blood dendritic cells in chronic myeloid leukaemia patients correlate with loss of CD34+\/CD38\u2212 primitive haematopoietic progenitors.","volume":"119","author":"Mohty","year":"2002","journal-title":"Br J Haematol"},{"key":"2019111722345052500_B10","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.leu.2403474","article-title":"Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate.","volume":"18","author":"Boissel","year":"2004","journal-title":"Leukemia"},{"key":"2019111722345052500_B11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2141.2003.03979.x","article-title":"Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia.","volume":"120","author":"Eisendle","year":"2003","journal-title":"Br J Haematol"},{"key":"2019111722345052500_B12","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0301-472X(99)00055-7","article-title":"Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha.","volume":"27","author":"Wang","year":"1999","journal-title":"Exp Hematol"},{"key":"2019111722345052500_B13","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood.V98.13.3750","article-title":"Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment.","volume":"98","author":"Mohty","year":"2001","journal-title":"Blood"},{"key":"2019111722345052500_B14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/152581600319676","article-title":"Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells.","volume":"9","author":"Dietz","year":"2000","journal-title":"J Hematother Stem Cell Res"},{"key":"2019111722345052500_B15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2141.2007.06547.x","article-title":"Vaccination with autologous non-irradiated dendritic cells in patients with bcr\/abl+ chronic myeloid leukaemia.","volume":"137","author":"Westermann","year":"2007","journal-title":"Br J Haematol"},{"key":"2019111722345052500_B16","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","article-title":"Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow.","volume":"92","author":"Pear","year":"1998","journal-title":"Blood"},{"key":"2019111722345052500_B17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1084\/jem.187.5.763","article-title":"Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology.","volume":"187","author":"Ehl","year":"1998","journal-title":"J Exp Med"},{"key":"2019111722345052500_B18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/342559a0","article-title":"Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.","volume":"342","author":"Pircher","year":"1989","journal-title":"Nature"},{"key":"2019111722345052500_B19","first-page":"136","article-title":"Versatile retroviral vectors for potential use in gene therapy.","volume":"1","author":"Hawley","year":"1994","journal-title":"Gene Ther"},{"key":"2019111722345052500_B20","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood.V90.5.1777","article-title":"Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo.","volume":"90","author":"Persons","year":"1997","journal-title":"Blood"},{"key":"2019111722345052500_B21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood.V83.1.43.43","article-title":"kat: a high-efficiency retroviral transduction system for primary human T lymphocytes.","volume":"83","author":"Finer","year":"1994","journal-title":"Blood"},{"key":"2019111722345052500_B22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.164.4.1075","article-title":"T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus: liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?","volume":"164","author":"Zinkernagel","year":"1986","journal-title":"J Exp Med"},{"key":"2019111722345052500_B23","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1182\/blood-2006-04-018705","article-title":"Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections.","volume":"108","author":"Mumprecht","year":"2006","journal-title":"Blood"},{"key":"2019111722345052500_B24","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V92.10.3829","article-title":"Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia.","volume":"92","author":"Zhang","year":"1998","journal-title":"Blood"},{"key":"2019111722345052500_B25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells.","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"2019111722345052500_B26","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ni1385","article-title":"Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus.","volume":"7","author":"Bonasio","year":"2006","journal-title":"Nat Immunol"},{"key":"2019111722345052500_B27","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0301-472X(99)00091-0","article-title":"Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis.","volume":"27","author":"Lickliter","year":"1999","journal-title":"Exp Hematol"},{"key":"2019111722345052500_B28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1172\/JCI200316398","article-title":"Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.","volume":"111","author":"Molldrem","year":"2003","journal-title":"J Clin Invest"},{"key":"2019111722345052500_B29","first-page":"1242","article-title":"Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy.","volume":"63","author":"Schimmer","year":"2003","journal-title":"Cancer Res"},{"key":"2019111722345052500_B30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","article-title":"The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.","volume":"189","author":"Li","year":"1999","journal-title":"J Exp Med"},{"key":"2019111722345052500_B31","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1182\/blood.V89.4.1133","article-title":"Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia.","volume":"89","author":"Choudhury","year":"1997","journal-title":"Blood"},{"key":"2019111722345052500_B32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3121\/cmr.3.3.166","article-title":"Immunoregulation of dendritic cells.","volume":"3","author":"Wallet","year":"2005","journal-title":"Clin Med Res"},{"key":"2019111722345052500_B33","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.febslet.2007.02.048","article-title":"Upregulation of the TGFbeta signalling pathway by Bcr-Abl: implications for haemopoietic cell growth and chronic myeloid leukaemia.","volume":"581","author":"Moller","year":"2007","journal-title":"FEBS Lett"},{"key":"2019111722345052500_B34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.leu.2404549","article-title":"Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.","volume":"21","author":"Diaz-Blanco","year":"2007","journal-title":"Leukemia"},{"key":"2019111722345052500_B35","first-page":"359","article-title":"Different types of human leukemias express the message for TNF-alpha and interleukin-10.","volume":"6","author":"Schulz","year":"2001","journal-title":"Eur J Med Res"},{"key":"2019111722345052500_B36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s002620050619","article-title":"IFN-alpha regulates IL 10 production by CML cells in vitro.","volume":"48","author":"Pawelec","year":"1999","journal-title":"Cancer Immunol Immunother"},{"key":"2019111722345052500_B37","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1038\/sj.onc.1206607","article-title":"Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells.","volume":"22","author":"Coppo","year":"2003","journal-title":"Oncogene"},{"key":"2019111722345052500_B38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2006.06161.x","article-title":"BCR-ABL activates STAT3 via JAK and MEK pathways in human cells.","volume":"134","author":"Coppo","year":"2006","journal-title":"Br J Haematol"},{"key":"2019111722345052500_B39","doi-asserted-by":"crossref","first-page":"9525","DOI":"10.1158\/0008-5472.CAN-05-0529","article-title":"Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2\/signal transducers and activators of transcription 3 pathway.","volume":"65","author":"Nefedova","year":"2005","journal-title":"Cancer Res"},{"key":"2019111722345052500_B40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1196\/annals.1392.015","article-title":"Flt3 in regulation of type I interferon-producing cell and dendritic cell development.","volume":"1106","author":"Onai","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"2019111722345052500_B41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nm976","article-title":"Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells.","volume":"10","author":"Wang","year":"2004","journal-title":"Nat Med"},{"key":"2019111722345052500_B42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.coph.2006.01.010","article-title":"Understanding and exploiting the endogenous interleukin-10\/STAT3-mediated anti-inflammatory response.","volume":"6","author":"Murray","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"2019111722345052500_B43","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/35082583","article-title":"Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction.","volume":"411","author":"Ochsenbein","year":"2001","journal-title":"Nature"},{"key":"2019111722345052500_B44","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nm1489","article-title":"Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells.","volume":"12","author":"Krause","year":"2006","journal-title":"Nat Med"},{"key":"2019111722345052500_B45","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1182\/blood.V91.9.3414","article-title":"Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores beta1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors.","volume":"91","author":"Bhatia","year":"1998","journal-title":"Blood"},{"key":"2019111722345052500_B46","first-page":"4233","article-title":"The BCR\/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha.","volume":"94","author":"Salgia","year":"1999","journal-title":"Blood"},{"key":"2019111722345052500_B47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri1085","article-title":"Negative selection: clearing out the bad apples from the T-cell repertoire.","volume":"3","author":"Palmer","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"2019111722345052500_B48","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1146\/annurev.immunol.23.021704.115601","article-title":"A central role for central tolerance.","volume":"24","author":"Kyewski","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"2019111722345052500_B49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1471-4906(02)00038-8","article-title":"A central role for peripheral dendritic cells in the induction of acquired thymic tolerance.","volume":"24","author":"Goldschneider","year":"2003","journal-title":"Trends Immunol"},{"key":"2019111722345052500_B50","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/19\/4681\/1484727\/zh801909004681.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/19\/4681\/1484727\/zh801909004681.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T03:35:25Z","timestamp":1574048125000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/113\/19\/4681\/25930\/Defective-homing-and-impaired-induction-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,7]]},"references-count":50,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2009,5,7]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-05-156471","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,7]]}}}